Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139032756> ?p ?o ?g. }
- W2139032756 endingPage "90" @default.
- W2139032756 startingPage "81" @default.
- W2139032756 abstract "alpha-1-Antichymotrypsin (ACT) is present in neuritic plaques in which it participates in the inflammatory cascade of Alzheimer's disease (AD). Reports of blood ACT levels in AD, and its usefulness as a disease biomarker, have been conflicting. In an effort to clarify this, we measured plasma ACT levels in 516 white subjects including 359 subjects with probable or possible AD, 44 subjects with other late-life dementias, and 113 nondemented people. Subjects with systemic inflammatory diseases or who were taking antiinflammatory medications were excluded. All patients underwent extensive medical and detailed neuropsychological examinations at the time their blood was drawn. We found that plasma ACT levels were elevated in AD patients compared with the control group (p = 0.01) and were associated with severity of AD dementia; there was a negative association with the Mattis Dementia Rating Scale (a global measure of cognition) and a positive association with the Clinical Dementia Rating Scale (a global functional assessment). These relationships remained significant after controlling for demographic and genetic variables. When AD subjects were stratified into subgroups by dementia severity, matched by age, education, and gender, increased serum ACT correlated with Clinical Dementia Rating Scale (p = 0.0041) or Mattis Dementia Rating Scale (p = 0.0031) scores. ACT measurements in cerebrospinal fluid from an additional 34 AD cases and 16 controls showed elevated levels (p = 0.02) in AD. There was a negative correlation (p = 0.037) between cerebrospinal fluid ACT levels and clinical severity as measured by the Mini-Mental State Examination. Our results demonstrate that peripheral ACT levels are elevated in AD, but not in dementias other than AD, and they increase with progression of AD dementia. Although not useful as a diagnostic biomarker, ACT may reflect disease severity and may be helpful as a within subject biomarker in interventions (particularly with antiinflammatory agents) directed at slowing or halting progression of disease." @default.
- W2139032756 created "2016-06-24" @default.
- W2139032756 creator A5010114260 @default.
- W2139032756 creator A5021171640 @default.
- W2139032756 creator A5036815556 @default.
- W2139032756 creator A5039832836 @default.
- W2139032756 creator A5051629477 @default.
- W2139032756 creator A5057414041 @default.
- W2139032756 creator A5062088708 @default.
- W2139032756 creator A5065262676 @default.
- W2139032756 creator A5071364728 @default.
- W2139032756 creator A5082479521 @default.
- W2139032756 creator A5088223178 @default.
- W2139032756 creator A5088688660 @default.
- W2139032756 date "2002-12-18" @default.
- W2139032756 modified "2023-10-17" @default.
- W2139032756 title "Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment" @default.
- W2139032756 cites W1971805587 @default.
- W2139032756 cites W1972891705 @default.
- W2139032756 cites W1982831497 @default.
- W2139032756 cites W1984997717 @default.
- W2139032756 cites W1993057071 @default.
- W2139032756 cites W1998592142 @default.
- W2139032756 cites W2004105145 @default.
- W2139032756 cites W2006931715 @default.
- W2139032756 cites W2014959731 @default.
- W2139032756 cites W2017512075 @default.
- W2139032756 cites W2021333248 @default.
- W2139032756 cites W2026261993 @default.
- W2139032756 cites W2030424061 @default.
- W2139032756 cites W2032354232 @default.
- W2139032756 cites W2037249780 @default.
- W2139032756 cites W2042086026 @default.
- W2139032756 cites W2044991634 @default.
- W2139032756 cites W2045554741 @default.
- W2139032756 cites W2049588693 @default.
- W2139032756 cites W2051518061 @default.
- W2139032756 cites W2053022147 @default.
- W2139032756 cites W2054126953 @default.
- W2139032756 cites W2055335965 @default.
- W2139032756 cites W2056702221 @default.
- W2139032756 cites W2057290284 @default.
- W2139032756 cites W2058124777 @default.
- W2139032756 cites W2061388978 @default.
- W2139032756 cites W2061576298 @default.
- W2139032756 cites W2065751583 @default.
- W2139032756 cites W2066819961 @default.
- W2139032756 cites W2068963435 @default.
- W2139032756 cites W2073794686 @default.
- W2139032756 cites W2076115380 @default.
- W2139032756 cites W2076582776 @default.
- W2139032756 cites W2078280064 @default.
- W2139032756 cites W2079786853 @default.
- W2139032756 cites W2089471300 @default.
- W2139032756 cites W2104932745 @default.
- W2139032756 cites W2122506534 @default.
- W2139032756 cites W2134699710 @default.
- W2139032756 cites W2136250824 @default.
- W2139032756 cites W2152410944 @default.
- W2139032756 cites W2156220037 @default.
- W2139032756 cites W2161929150 @default.
- W2139032756 cites W2167754585 @default.
- W2139032756 cites W2312933856 @default.
- W2139032756 cites W4251308908 @default.
- W2139032756 doi "https://doi.org/10.1002/ana.10414" @default.
- W2139032756 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12509851" @default.
- W2139032756 hasPublicationYear "2002" @default.
- W2139032756 type Work @default.
- W2139032756 sameAs 2139032756 @default.
- W2139032756 citedByCount "85" @default.
- W2139032756 countsByYear W21390327562012 @default.
- W2139032756 countsByYear W21390327562013 @default.
- W2139032756 countsByYear W21390327562014 @default.
- W2139032756 countsByYear W21390327562016 @default.
- W2139032756 countsByYear W21390327562017 @default.
- W2139032756 countsByYear W21390327562019 @default.
- W2139032756 countsByYear W21390327562020 @default.
- W2139032756 countsByYear W21390327562021 @default.
- W2139032756 countsByYear W21390327562022 @default.
- W2139032756 countsByYear W21390327562023 @default.
- W2139032756 crossrefType "journal-article" @default.
- W2139032756 hasAuthorship W2139032756A5010114260 @default.
- W2139032756 hasAuthorship W2139032756A5021171640 @default.
- W2139032756 hasAuthorship W2139032756A5036815556 @default.
- W2139032756 hasAuthorship W2139032756A5039832836 @default.
- W2139032756 hasAuthorship W2139032756A5051629477 @default.
- W2139032756 hasAuthorship W2139032756A5057414041 @default.
- W2139032756 hasAuthorship W2139032756A5062088708 @default.
- W2139032756 hasAuthorship W2139032756A5065262676 @default.
- W2139032756 hasAuthorship W2139032756A5071364728 @default.
- W2139032756 hasAuthorship W2139032756A5082479521 @default.
- W2139032756 hasAuthorship W2139032756A5088223178 @default.
- W2139032756 hasAuthorship W2139032756A5088688660 @default.
- W2139032756 hasConcept C118552586 @default.
- W2139032756 hasConcept C126322002 @default.
- W2139032756 hasConcept C138496976 @default.
- W2139032756 hasConcept C14216870 @default.
- W2139032756 hasConcept C15744967 @default.